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Erythematosus, Maps to Chromosome 3p
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Systemic lupus erythematosus is a prototypic autoimmune disease. Apart from raremonogenic deﬁciencies of complement
factors, where lupuslike diseasemay occur in associationwith other autoimmune diseases or high susceptibility tobacterial
infections, its etiology is multifactorial in nature. Cutaneous ﬁndings are a hallmark of the disease and manifest either
alone or in association with internal-organ disease. We describe a novel genodermatosis characterized by painful bluish-
red inﬂammatory papular or nodular lesions in acral locations such as ﬁngers, toes, nose, cheeks, and ears. The lesions
sometimes appear plaquelike and tend to ulcerate. Manifestation usually begins in early childhood and is precipitated
by cold and wet exposure. Apart from arthralgias, there is no evidence for internal-organ disease or an increased sus-
ceptibility to infection. Histological ﬁndings include a deep inﬂammatory inﬁltrate with perivascular distribution and
granular deposits of immunoglobulins and complement along the basement membrane. Some affected individuals show
antinuclear antibodies or immune complex formation, whereas cryoglobulins or cold agglutinins are absent. Thus, the
ﬁndings are consistent with chilblain lupus, a rare form of cutaneous lupus erythematosus. Investigation of a large
German kindred with 18 affected members suggests a highly penetrant trait with autosomal dominant inheritance. By
single-nucleotide-polymorphism–based genomewide linkage analysis, the locus was mapped to chromosome 3p. Hap-
lotype analysis deﬁned the locus to a 13.8-cM interval with a LOD score of 5.04. This is the ﬁrst description of amonogenic
form of cutaneous lupus erythematosus. Identiﬁcation of the gene responsible for familial chilblain lupus may shed light
on the pathogenesis of common forms of connective-tissue disease such as systemic lupus erythematosus.
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Systemic lupus erythematosus is a complex autoimmune
disease with a prevalence of 0.06% in the general popu-
lation. Its etiology is multifactorial and is inﬂuenced by
both genetic and environmental factors.1,2 Cutaneous
ﬁndings are a hallmark of the disease and include butterﬂy
rash, discoid lesions, oral ulcers, and alopecia.3 Moreover,
4 of the 11 diagnostic criteria for systemic lupus erythe-
matosus comprise cutaneous ﬁndings.4 The formation of
immune complexes consisting of autoantibodies against
nuclear antigens is thought to be the principal cause of
the inﬂammatory process leading to skin rashes, vasculitis,
arthritis, and nephritis.4,5 To date, several susceptibility
loci have been identiﬁed by both genomewide and asso-
ciation approaches.1,2 However, most of the genetic basis
and the molecular pathogenesis of lupus erythematosus
remains undeﬁned.
Apart from autosomal recessively inherited deﬁciencies
of complement factors, which play an important role in
adaptive immunity, no monogenic form of lupus erythe-
matosus has been identiﬁed so far. Thus, selective deﬁ-
ciency of C1q, C1r, C1s, C2, or C4a has been associated
with multiple autoimmune diseases, including a lupuslike
phenotype,6–9 whereas selective deﬁciency of C3 and C5
leads to high susceptibility to bacterial infections in ad-
dition to lupuslike phenotypes.10,11
In the present study, we describe a large, nonconsan-
guineous German family with 18 members over 5 gen-
erations affected with chilblain lupus, a rare cutaneous
form of lupus erythematosus (ﬁg. 1). Affected individuals
presented with painful bluish-red papular or nodular le-
sions of the skin in acral locations—including the dorsal
aspects of ﬁngers and toes, heels, nose, cheeks, ears, and,
in some cases, also knees—precipitated by cold and wet
exposure at temperatures !10C (ﬁg. 2). Sometimes a
plaquelike appearance was noted, and ulcerationwas com-
monly seen. Although deep ulceration led to necrotic de-
struction of the distal interphalangeal joint of the left ﬁfth
ﬁnger in the index patient at age 15 years, the lesions
usually healedwithout scars, occasionally leavingatrophic
skin and pigmentary changes. The onset of the skin lesions
was in early childhood, and, in most patients, the lesions
tended to improve during summer. Mucous membranes
and nails were not affected, although subungual lesions
were sometimes seen. There was no associated Raynaud
phenomenon or photosensitivity. Apart from arthralgias
affecting mainly large joints, such as knees and shoulders,
there was no history of associated disease of any internal
organ (including the CNS), immune deﬁciency, or malig-
nancy. Serological data were available from seven affected
individuals. There was no evidence for cryoglobulinemia,
cryoﬁbrinogenemia, hypergammaglobulinemia, irregular
antibodies, cold agglutinins, viral or bacterial infection,
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Figure 1. Pedigree of the family with chilblain lupus. The arrow indicates the index patient. The asterisks (*) indicate family members
included in the genomewide linkage analysis.
Table 1. Phenotypic Data of Seven Affected Individuals
Individual
Age at Onset
(years)
Distribution of
Skin Lesions Additional Findings Laboratory Findingsa
Histology
Consistent
with
Lupusb
V1 1 Fingers, toes, face, ears Arthralgia (knees, shoulders), ne-
crosis of distal left ﬁfth ﬁnger
Unremarkable Yes
V2 3 Fingers, toes, heels, knees None Unremarkable NA
IV2 2 Fingers, toes, heels, knees Arthralgia (knees, shoulders) Decreased C4 complement Yes
V12 3 Fingers, toes, ears None C3d binding immune complexes NA
V11 1 Fingers, toes, face, ears None Unremarkable NA
IV11 3 Fingers, toes, heels Arthralgia (knees) ANA (1:300) speckled and ho-
mogenous pattern
Yes
III4 3 Fingers, toes, ears Arthralgia (knees, ﬁngers, spine) ANA (1:300) speckled pattern NA
a Laboratory workup included complete blood count with differential, cryoglobulins, cryoﬁbrinogen, cold agglutinins, autoantibodies (antinuclear
antibodies [ANA], cardiolipin IgA/IgG/IgM, phosphatidylserin IgA/IgG/IgM, ssDNA, dsDNA, Ro/SSA, La/SSB, Sm, U1RNP, Scl-70, Jo), rheumatic
factor, direct Coombs test, irregular antibodies, complement (C1q, C3c, C4), total hemolytic complement, circulating immune complexes (C1q and
C3d binding), serum electrophoresis, signs of viral and bacterial infection (hepatitis A, B, and C, cytomegaly virus, borrelia burgdorferi, streptococci),
liver transaminases, and urine analysis.
b NA p not analyzed.
rheumatic factor, or anticardiolipin antibodies (table 1).
In two cases, antinuclear antibodies were found, although
further differentiation did not show the presence of
known nuclear autoantibodies (table 1). One affected
child was found to have increased C3d-binding circulating
immune complexes, and one affected woman showed de-
creased levels of C4 complement, indicating the formation
of immune complexes (table 1).
Three affected individuals underwent biopsy of skin le-
sions for histological analysis. Staining with hematoxylin-
eosin, Alcian blue, and periodic acid Schiff (PAS) anddirect
immunoﬂuorescence against IgG, IgM, IgA, and C3 were
performed according to standard procedures. The histol-
ogy showed characteristic ﬁndings of lupus erythemato-
sus, whereas edematous changes or intraluminal ﬁbrin—
which are typically seen in true cold-induced perniosis
or cryoglobulinemia, respectively—were absent (ﬁg. 3).
There was a lamellar orthohyperkeratosis within a regu-
larly built epidermis. The junctional zone showed areas
of hydropic degeneration of the stratum basale and oc-
casional single-cell necrosis. A pronounced superﬁcial and
deep lymphocytic and histiocytic inﬁltration, with periad-
nexial and perivascular distribution along with interface
dermatitis, could be seen. Throughout the stratum reti-
culare, there were increased mucin deposits (ﬁg. 3). PAS
staining revealed discrete broadening of the basement
membrane without intraluminal ﬁbrin deposits (data not
shown). Direct immunoﬂuorescence showed granular de-
posits of IgM and IgA immunoglobulins and C3 comple-
ment within the basement membrane zone (ﬁg. 3). Thus,
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Figure 2. Cutaneous ﬁndings. A, Hands of proband (V1) at 6 years of age and his mother (IV2) at 30 years of age, showing multiple
ulcerating nodular lesions over dorsal aspects of ﬁngers and knuckles. B, Dorsal feet and left heel with purpuric appearance of individual
IV2. C, Left ear of individual V11 at 3 years of age, with ulcerating lesion. D, Face and hands of individual V1 at 8 years of age. The
erythematous plaquelike lesions over cheeks, nose, and chin resemble butterﬂy rash. E, Fingers showing fresh lesions, which appear as
bluish-red, indurated, and tender papules.
the ﬁndings in this family were consistent with the di-
agnosis of chilblain lupus, a rare cutaneous form of
lupus erythematosus, which was ﬁrst described by Hutch-
inson.12 The presence of histological and serological ﬁnd-
ings typically seen in lupus constitutes diagnostic criteria
and differentiates chilblain lupus from true cold-induced
perniosis or chilblains.13 The distinct morphology and dis-
tribution of the lesions, together with the absence of pho-
tosensitivity and autoantibodies against Ro/SSA and La/
SSB, distinguish the phenotype of this family from sub-
acute cutaneous lupus erythematosus. Chilblain lupus oc-
curs predominantly in adult women and has only rarely
been described in children.14,15 Apart from two affected
brothers, no familial occurrence had been described at the
time of this study.15 Progression to systemic lupus erythe-
matosus has been reported in up to 18% of affected in-
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Figure 3. Histology of lesional skin biopsy from proband V1. A, Hematoxylin-eosin staining (magniﬁcation 1:100) showing lamellar
orthohyperkeratosis and regions of hydropic degeneration of the stratum basale as well as single-cell necrosis. Inﬂammatory inﬁltrates
with perivascular and periadnexial distribution and interface dermatitis can be seen. B, Alcian blue staining (magniﬁcation 1:40)
showing increased deposits of mucin throughout entire stratum reticulare. C, Direct immune ﬂuorescence (magniﬁcation 1:100) showing
broad granular deposits of C3 along basement membrane zone. A similar pattern was also seen with staining for IgM or IgA.
Figure 4. Graphic summary of linkage analysis. A, Parametric
linkage results identifying a single locus on chromosome 3p. B,
Relative position of markers and reﬁned physical interval for chil-
blain lupus, on the basis of haplotype analysis and genotyping of
additional microsatellite markers. Key recombinant markers are
marked in bold. AGS1 p Aicardi-Goutie`res syndrome, type 1.
dividuals, which is comparable to the progression rate of
classic chronic cutaneous lupus erythematosus.14
The vertical transmission of the disease in both males
and females and the consistency of the phenotype sug-
gested autosomal dominant inheritance with high pene-
trance. The phenotype of all family members was estab-
lished through direct clinical examination or review of
medical records. All participating individuals granted in-
formed written consent before the study. To map the dis-
ease locus, whole-genome linkage analysis was performed
on genomic DNA from peripheral blood leukocytes from
26 family members, including 14 affected individuals, by
use of the Affymetrix GeneChip Human Mapping 10K
Xba 142 2.0 Array. Genotyping of microsatellite markers
was performed with ﬂuorescently labeled primers on an
ABI3100 Sequencer (Applied Biosystems). GRR and Ped-
Check were used to verify relationship and sex and to
identify Mendelian errors.16,17 Nonparametric and para-
metric linkage analysis was done with Merlin, version
1.0.18 For parametric analysis, an autosomal dominant
trait with a penetrance of 99%, without phenocopy, and
a disease allele frequency of 0.001 were assumed. The dis-
ease locus was localized on chromosome 3p21–3p14, with
a maximum LOD score of 5.04 (ﬁg. 4). Nonparametric
analysis conﬁrmed this locus, with a Z-mean score of 6.2.
A common haplotype was identiﬁed that was present in
all affected and absent in all unaffected individuals. On
the basis of critical recombination events in two affected
individuals, the disease interval was deﬁned to a 13.8-cM
region delimited by markers rs704920 and d3s1300 (ﬁg.
4). The mapped interval comprises 16.4 Mb and includes
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Table 2. List of Genes Screened for Mutations by Comparative
Sequencing
Gene Name
Gene
Symbol
Accession
Numbera
Toll-like receptor 9 TLR9 MIM *605474
Deoxyribonuclease I-like 3 DNASE1L3 MIM *602244
Ubiquitin-activating enzyme E1-like UBE1L MIM *191325
Protein kinase C delta PRKCD MIM *176977
Interleukin 17 receptor B IL17RB MIM *605458
Interleukin 17 receptor D IL17RD MIM *606807
Chemokine, CC motif, receptor 9 CCR9 MIM *604738
Chemokine, CXC motif, receptor 6 CXCR6 MIM *605163
Chemokine, C motif, receptor 1 XCR1 MIM *600552
Chemokine, CC motif, receptor 1 CCR1 MIM *601159
Chemokine, CC motif, receptor 2 CCR2 MIM *601267
Chemokine, CC motif, receptor 5 CCR3 MIM *601268
Chemokine, CC motif, receptor 5 CCR5 MIM *601373
Chemokine, CC motif, receptor-like protein 2 CCRL2 MIM *608379
Collagen VII alpha-1 COL7A1 MIM *120120
Chemokine-binding protein 2 CCBP2 MIM *602848
Cytokine-inducible SH2-containing protein CISH MIM *602441
C-type lectin domain family 3, member B CLEC3B NM_003278
Decapping enzyme 1 DCP1A MIM *607010
Family with sequence similarity 3, member 3 FAM3D MIM *608619
Hyaluronidase 2 HYAL2 MIM *603551
Interferon-related developmental regulator 2 IFRD2 MIM *602725
Inositol hexaphosphate kinase 1 IHPK1 MIM *606991
Inositol hexaphosphate kinase 2 IHPK2 MIM *606992
Leucine-rich repeat-containing protein 2 LRRC2 MIM *607180
Leucine zipper transcription factor-like 1 LZTFL1 MIM *606568
Macrophage stimulating 1 MST1 MIM *142408
Macrophage stimulating 1 receptor MST1R MIM *600168
Natural killer tumor recognition sequence NKTR MIM *161565
Protein phosphatase, 1M PP2CE MIM *608979
Ring ﬁnger protein 123 RNF123 NM_022064
Stabilin 1 STAB1 MIM *608560
TRAF-interacting protein TRIP MIM *605958
Ubiquitin-speciﬁc protease 4 USP4 MIM *603486
a For genes not listed in the OMIM database, a representative RefSeq accession
number is listed.
1100 known genes (Ensembl v38). By systematic mining
of the Ensembl and GeneCards databases, the function
and expression of all genes were investigated, and can-
didate genes were selected for sequencing. All coding ex-
ons, including ﬂanking intronic regions, were sequenced
in two affected individuals and two unrelated, healthy
control individuals on an ABI3100 sequencer, accord-
ing to standard procedures. Priority was given to genes
that had been implicated in the pathogenesis of lupus
erythematosus or other autoimmune diseases, such as
the genes encoding toll-like receptor 9 (TLR9 [MIM
*605474]),19,20 deoxyribonuclease I-like 3 (DNASE1L3
[MIM *602244]),5,21 ubiquitin-activating enzyme E1-like
(UBE1L [MIM *191325]),22 protein kinase C delta (PRKCD
[MIM *176977]),23,24 interleukin 17 receptors B and D
(IL17RB [MIM *605458] and IL17RD [MIM *606807]),25
and the chemokine receptor cluster (CCR9 [MIM
*604738], CXCR6 [MIM *605163], XCR1 [MIM *600552],
CCR1 [MIM *601159], CCR2 [MIM *601267], CCR3 [MIM
*601268], CCR5 [MIM *601373], and CCRL2 [MIM
*608379]).26,27 We also investigated the collagen VII alpha-
1 gene (COL7A1 [MIM *120120]), since it is highly ex-
pressed in the skin and known to cause autosomal dom-
inant bullous epidermolysis dystrophica (MIM *131750),
although blistering is not a feature of chilblain lupus. A
complete list of genes analyzed for mutations so far is
given in table 2. Several known and novel SNPs were iden-
tiﬁed, but no pathogenic mutation was observed within
the regions analyzed. All novel coding SNPs were inter-
rogated for segregation with the trait and their allele fre-
quencies estimated by genotyping 100 unrelated healthy
controls (data not shown).
Interestingly, the locus mapped for chilblain lupus over-
laps with a locus for Aicardi-Goutie`res syndrome 1 (AGS1
[MIM *225750]), a progressive encephalopathy, which
mimicks congenital viral infection.28 Aicardi-Goutie`res
syndrome is identical to pseudo-TORCH syndrome (MIM
*251290) and Cree encephalitis (MIM *608505)29 and has
been shown to be genetically heterogeneous. Thus, in ad-
dition to the locus on chromosome 3p, there is evidence
for a second locus on chromosome 13q.30 Children af-
fected with Aicardi-Goutie`res syndrome suffer from pro-
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gressive microcephaly and severe cerebral dysfunction as-
sociated with calciﬁcation of basal ganglia, chronic
lymphocytosis, and elevated interferon alpha in the spinal
ﬂuid.28,31 Most patients die in early childhood. Some pa-
tients have chilblainlike lesions that resemble those found
in the family studied here, although unaffected parents
appear not to show any cutaneous ﬁndings.31,32 Moreover,
Aicardi-Goutie`res syndrome has been suggested to be a
form of systemic lupus erythematosus, because of the ﬁnd-
ings of hypocomplementemia and antinuclear autoanti-
bodies in addition to lupuslike skin lesions in some pa-
tients.33–36 Therefore, it is possible that chilblain lupus and
Aicardi-Goutie`res syndrome are allelic phenotypes repre-
senting different spectrums of the same disease, although
the exact molecular mechanisms and the different modes
of inheritance remain to be clariﬁed.
Systemic lupus erythematosus is a complex polygenic
disease and is considered a prototypic autoimmune dis-
ease. The observation that the locus identiﬁed in this study
does not localize within any hitherto mapped suscepti-
bility locus for systemic lupus erythematosus does not pre-
clude it from playing a major role,1,2 since previous studies
of complex diseases have demonstrated that genomewide
and association approaches may lead to completely dif-
ferent results. Thus, further investigation of the potential
signiﬁcance of this locus for common forms of lupus er-
ythematosus is warranted.
The clinical spectrum of systemic lupus erythematosus
is very broad, encompassing exclusive internal-organ dis-
ease, exclusive cutaneous ﬁndings, and both internal and
cutaneous ﬁndings. It is likely that different genetic causes
determine at which end of the phenotypic spectrum a
susceptible individual will manifest the disease. In con-
trast with other monogenic diseases that have lupuslike
features, the phenotype presented here displays only fea-
tures seen in sporadic cutaneous lupus erythematosus,
suggesting that the underlying genetic cause also contrib-
utes to genetic susceptibility to common forms of cuta-
neous lupus erythematosus. With all observations taken
together, we have described a novel genodermatosis
termed “familial chilblain lupus” and have mapped its
genetic locus to chromosome 3p. Identiﬁcation of the re-
sponsible gene may shed light on the pathogenesis of
common forms of connective-tissue disease, such as sys-
temic lupus erythematosus.
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